Thomas Cueni is the director general of the International Federation of Pharmaceutical Manufacturers & Associations, which he has led since 2017. During this time, he has been instrumental in establishing cross-sectoral programs designed to tackle the biggest global health challenges. Thomas galvanized the industry to develop the Berlin Declaration — the pharmaceutical industry's blueprint to deliver equitable access to vaccines, treatments, and diagnostics in future pandemics. He also serves as chair of the business at OECD Health Committee and as industry co-chair of the APEC Biopharmaceutical Working Group on Ethics. He is also a member of the Business Advisory Group established by the director-general of the World Trade Organization.
